0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting ESAs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-25Z18204
Home | Market Reports | Health| Health Conditions
Global Long acting ESAs Market Research Report 2024
BUY CHAPTERS

Global Long-acting ESAs Market Research Report 2024

Code: QYRE-Auto-25Z18204
Report
October 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Long-acting ESAs Market

Long-acting erythropoiesis-stimulating agents (ESAs) are medications designed to stimulate red blood cell production over an extended period, reducing the frequency of administration compared to traditional ESAs. These drugs, such as darbepoetin alfa and methoxy polyethylene glycol-epoetin beta, are modified to have a prolonged half-life, allowing for less frequent dosing—typically once every two to four weeks—while maintaining their effectiveness in treating anemia. Long-acting ESAs are commonly used to treat anemia related to chronic kidney disease (CKD) and chemotherapy-induced anemia.
The global Long-acting ESAs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long-acting ESAs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-acting ESAs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-acting ESAs include Kyowa Kirin, Amgen, Dr. Reddy's Laboratories, Roche, Hansoh Pharma, Cipla, Sanwa Kagaku Kenkyusho, Kissei Pharmaceutical, Kyowa Hakko Kirin, Torrent Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting ESAs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting ESAs.
The Long-acting ESAs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting ESAs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting ESAs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting ESAs Market Report

Report Metric Details
Report Name Long-acting ESAs Market
Segment by Type
  • Darbepoetin Alfa
  • Methoxy Polyethylene Glycol-Epoetin Beta
  • Pegmolesatide
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kyowa Kirin, Amgen, Dr. Reddy's Laboratories, Roche, Hansoh Pharma, Cipla, Sanwa Kagaku Kenkyusho, Kissei Pharmaceutical, Kyowa Hakko Kirin, Torrent Pharmaceuticals, CKD Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting ESAs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting ESAs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Long-acting ESAs Market report?

Ans: The main players in the Long-acting ESAs Market are Kyowa Kirin, Amgen, Dr. Reddy's Laboratories, Roche, Hansoh Pharma, Cipla, Sanwa Kagaku Kenkyusho, Kissei Pharmaceutical, Kyowa Hakko Kirin, Torrent Pharmaceuticals, CKD Pharma

What are the Application segmentation covered in the Long-acting ESAs Market report?

Ans: The Applications covered in the Long-acting ESAs Market report are Renal Anemia, Cancer, Other

What are the Type segmentation covered in the Long-acting ESAs Market report?

Ans: The Types covered in the Long-acting ESAs Market report are Darbepoetin Alfa, Methoxy Polyethylene Glycol-Epoetin Beta, Pegmolesatide

Recommended Reports

Long-Acting Drug Markets

Anemia & Erythropoietin

Related Hematology Treatments

1 Long-acting ESAs Market Overview
1.1 Product Definition
1.2 Long-acting ESAs by Type
1.2.1 Global Long-acting ESAs Market Value Comparison by Type (2024-2030)
1.2.2 Darbepoetin Alfa
1.2.3 Methoxy Polyethylene Glycol-Epoetin Beta
1.2.4 Pegmolesatide
1.3 Long-acting ESAs by Application
1.3.1 Global Long-acting ESAs Market Value by Application (2024-2030)
1.3.2 Renal Anemia
1.3.3 Cancer
1.3.4 Other
1.4 Global Long-acting ESAs Market Size Estimates and Forecasts
1.4.1 Global Long-acting ESAs Revenue 2019-2030
1.4.2 Global Long-acting ESAs Sales 2019-2030
1.4.3 Global Long-acting ESAs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-acting ESAs Market Competition by Manufacturers
2.1 Global Long-acting ESAs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-acting ESAs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-acting ESAs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Long-acting ESAs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting ESAs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting ESAs, Product Type & Application
2.7 Global Key Manufacturers of Long-acting ESAs, Date of Enter into This Industry
2.8 Global Long-acting ESAs Market Competitive Situation and Trends
2.8.1 Global Long-acting ESAs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting ESAs Players Market Share by Revenue
2.8.3 Global Long-acting ESAs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting ESAs Market Scenario by Region
3.1 Global Long-acting ESAs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-acting ESAs Sales by Region: 2019-2030
3.2.1 Global Long-acting ESAs Sales by Region: 2019-2024
3.2.2 Global Long-acting ESAs Sales by Region: 2025-2030
3.3 Global Long-acting ESAs Revenue by Region: 2019-2030
3.3.1 Global Long-acting ESAs Revenue by Region: 2019-2024
3.3.2 Global Long-acting ESAs Revenue by Region: 2025-2030
3.4 North America Long-acting ESAs Market Facts & Figures by Country
3.4.1 North America Long-acting ESAs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-acting ESAs Sales by Country (2019-2030)
3.4.3 North America Long-acting ESAs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting ESAs Market Facts & Figures by Country
3.5.1 Europe Long-acting ESAs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-acting ESAs Sales by Country (2019-2030)
3.5.3 Europe Long-acting ESAs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting ESAs Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting ESAs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-acting ESAs Sales by Region (2019-2030)
3.6.3 Asia Pacific Long-acting ESAs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting ESAs Market Facts & Figures by Country
3.7.1 Latin America Long-acting ESAs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-acting ESAs Sales by Country (2019-2030)
3.7.3 Latin America Long-acting ESAs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting ESAs Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting ESAs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-acting ESAs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-acting ESAs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting ESAs Sales by Type (2019-2030)
4.1.1 Global Long-acting ESAs Sales by Type (2019-2024)
4.1.2 Global Long-acting ESAs Sales by Type (2025-2030)
4.1.3 Global Long-acting ESAs Sales Market Share by Type (2019-2030)
4.2 Global Long-acting ESAs Revenue by Type (2019-2030)
4.2.1 Global Long-acting ESAs Revenue by Type (2019-2024)
4.2.2 Global Long-acting ESAs Revenue by Type (2025-2030)
4.2.3 Global Long-acting ESAs Revenue Market Share by Type (2019-2030)
4.3 Global Long-acting ESAs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-acting ESAs Sales by Application (2019-2030)
5.1.1 Global Long-acting ESAs Sales by Application (2019-2024)
5.1.2 Global Long-acting ESAs Sales by Application (2025-2030)
5.1.3 Global Long-acting ESAs Sales Market Share by Application (2019-2030)
5.2 Global Long-acting ESAs Revenue by Application (2019-2030)
5.2.1 Global Long-acting ESAs Revenue by Application (2019-2024)
5.2.2 Global Long-acting ESAs Revenue by Application (2025-2030)
5.2.3 Global Long-acting ESAs Revenue Market Share by Application (2019-2030)
5.3 Global Long-acting ESAs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Kyowa Kirin
6.1.1 Kyowa Kirin Company Information
6.1.2 Kyowa Kirin Description and Business Overview
6.1.3 Kyowa Kirin Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Kyowa Kirin Long-acting ESAs Product Portfolio
6.1.5 Kyowa Kirin Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Long-acting ESAs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Company Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Long-acting ESAs Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Long-acting ESAs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Hansoh Pharma
6.5.1 Hansoh Pharma Company Information
6.5.2 Hansoh Pharma Description and Business Overview
6.5.3 Hansoh Pharma Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hansoh Pharma Long-acting ESAs Product Portfolio
6.5.5 Hansoh Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Long-acting ESAs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho
6.7.1 Sanwa Kagaku Kenkyusho Company Information
6.7.2 Sanwa Kagaku Kenkyusho Description and Business Overview
6.7.3 Sanwa Kagaku Kenkyusho Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Sanwa Kagaku Kenkyusho Long-acting ESAs Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Recent Developments/Updates
6.8 Kissei Pharmaceutical
6.8.1 Kissei Pharmaceutical Company Information
6.8.2 Kissei Pharmaceutical Description and Business Overview
6.8.3 Kissei Pharmaceutical Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kissei Pharmaceutical Long-acting ESAs Product Portfolio
6.8.5 Kissei Pharmaceutical Recent Developments/Updates
6.9 Kyowa Hakko Kirin
6.9.1 Kyowa Hakko Kirin Company Information
6.9.2 Kyowa Hakko Kirin Description and Business Overview
6.9.3 Kyowa Hakko Kirin Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kyowa Hakko Kirin Long-acting ESAs Product Portfolio
6.9.5 Kyowa Hakko Kirin Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Company Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Torrent Pharmaceuticals Long-acting ESAs Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 CKD Pharma
6.11.1 CKD Pharma Company Information
6.11.2 CKD Pharma Description and Business Overview
6.11.3 CKD Pharma Long-acting ESAs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CKD Pharma Long-acting ESAs Product Portfolio
6.11.5 CKD Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting ESAs Industry Chain Analysis
7.2 Long-acting ESAs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting ESAs Production Mode & Process
7.4 Long-acting ESAs Sales and Marketing
7.4.1 Long-acting ESAs Sales Channels
7.4.2 Long-acting ESAs Distributors
7.5 Long-acting ESAs Customers
8 Long-acting ESAs Market Dynamics
8.1 Long-acting ESAs Industry Trends
8.2 Long-acting ESAs Market Drivers
8.3 Long-acting ESAs Market Challenges
8.4 Long-acting ESAs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Long-acting ESAs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Long-acting ESAs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Long-acting ESAs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Long-acting ESAs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Long-acting ESAs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Long-acting ESAs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Long-acting ESAs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Long-acting ESAs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Long-acting ESAs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting ESAs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting ESAs, Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting ESAs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting ESAs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting ESAs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting ESAs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Long-acting ESAs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Long-acting ESAs Sales Market Share by Region (2019-2024)
 Table 19. Global Long-acting ESAs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Long-acting ESAs Sales Market Share by Region (2025-2030)
 Table 21. Global Long-acting ESAs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Long-acting ESAs Revenue Market Share by Region (2019-2024)
 Table 23. Global Long-acting ESAs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Long-acting ESAs Revenue Market Share by Region (2025-2030)
 Table 25. North America Long-acting ESAs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Long-acting ESAs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Long-acting ESAs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Long-acting ESAs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Long-acting ESAs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Long-acting ESAs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Long-acting ESAs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Long-acting ESAs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Long-acting ESAs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Long-acting ESAs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Long-acting ESAs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Long-acting ESAs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Long-acting ESAs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Long-acting ESAs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Long-acting ESAs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Long-acting ESAs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Long-acting ESAs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Long-acting ESAs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Long-acting ESAs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Long-acting ESAs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Long-acting ESAs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Long-acting ESAs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Long-acting ESAs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Long-acting ESAs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Long-acting ESAs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Long-acting ESAs Sales (K Units) by Type (2019-2024)
 Table 51. Global Long-acting ESAs Sales (K Units) by Type (2025-2030)
 Table 52. Global Long-acting ESAs Sales Market Share by Type (2019-2024)
 Table 53. Global Long-acting ESAs Sales Market Share by Type (2025-2030)
 Table 54. Global Long-acting ESAs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Long-acting ESAs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Long-acting ESAs Revenue Market Share by Type (2019-2024)
 Table 57. Global Long-acting ESAs Revenue Market Share by Type (2025-2030)
 Table 58. Global Long-acting ESAs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Long-acting ESAs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Long-acting ESAs Sales (K Units) by Application (2019-2024)
 Table 61. Global Long-acting ESAs Sales (K Units) by Application (2025-2030)
 Table 62. Global Long-acting ESAs Sales Market Share by Application (2019-2024)
 Table 63. Global Long-acting ESAs Sales Market Share by Application (2025-2030)
 Table 64. Global Long-acting ESAs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Long-acting ESAs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Long-acting ESAs Revenue Market Share by Application (2019-2024)
 Table 67. Global Long-acting ESAs Revenue Market Share by Application (2025-2030)
 Table 68. Global Long-acting ESAs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Long-acting ESAs Price (US$/Unit) by Application (2025-2030)
 Table 70. Kyowa Kirin Company Information
 Table 71. Kyowa Kirin Description and Business Overview
 Table 72. Kyowa Kirin Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Kyowa Kirin Long-acting ESAs Product
 Table 74. Kyowa Kirin Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Amgen Long-acting ESAs Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Dr. Reddy's Laboratories Company Information
 Table 81. Dr. Reddy's Laboratories Description and Business Overview
 Table 82. Dr. Reddy's Laboratories Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Dr. Reddy's Laboratories Long-acting ESAs Product
 Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Roche Long-acting ESAs Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Hansoh Pharma Company Information
 Table 91. Hansoh Pharma Description and Business Overview
 Table 92. Hansoh Pharma Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Hansoh Pharma Long-acting ESAs Product
 Table 94. Hansoh Pharma Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Cipla Long-acting ESAs Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. Sanwa Kagaku Kenkyusho Company Information
 Table 101. Sanwa Kagaku Kenkyusho Description and Business Overview
 Table 102. Sanwa Kagaku Kenkyusho Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Sanwa Kagaku Kenkyusho Long-acting ESAs Product
 Table 104. Sanwa Kagaku Kenkyusho Recent Developments/Updates
 Table 105. Kissei Pharmaceutical Company Information
 Table 106. Kissei Pharmaceutical Description and Business Overview
 Table 107. Kissei Pharmaceutical Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Kissei Pharmaceutical Long-acting ESAs Product
 Table 109. Kissei Pharmaceutical Recent Developments/Updates
 Table 110. Kyowa Hakko Kirin Company Information
 Table 111. Kyowa Hakko Kirin Description and Business Overview
 Table 112. Kyowa Hakko Kirin Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Kyowa Hakko Kirin Long-acting ESAs Product
 Table 114. Kyowa Hakko Kirin Recent Developments/Updates
 Table 115. Torrent Pharmaceuticals Company Information
 Table 116. Torrent Pharmaceuticals Description and Business Overview
 Table 117. Torrent Pharmaceuticals Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Torrent Pharmaceuticals Long-acting ESAs Product
 Table 119. Torrent Pharmaceuticals Recent Developments/Updates
 Table 120. CKD Pharma Company Information
 Table 121. CKD Pharma Description and Business Overview
 Table 122. CKD Pharma Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. CKD Pharma Long-acting ESAs Product
 Table 124. CKD Pharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Long-acting ESAs Distributors List
 Table 128. Long-acting ESAs Customers List
 Table 129. Long-acting ESAs Market Trends
 Table 130. Long-acting ESAs Market Drivers
 Table 131. Long-acting ESAs Market Challenges
 Table 132. Long-acting ESAs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting ESAs
 Figure 2. Global Long-acting ESAs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Long-acting ESAs Market Share by Type: 2023 & 2030
 Figure 4. Darbepoetin Alfa Product Picture
 Figure 5. Methoxy Polyethylene Glycol-Epoetin Beta Product Picture
 Figure 6. Pegmolesatide Product Picture
 Figure 7. Global Long-acting ESAs Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Long-acting ESAs Market Share by Application: 2023 & 2030
 Figure 9. Renal Anemia
 Figure 10. Cancer
 Figure 11. Other
 Figure 12. Global Long-acting ESAs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Long-acting ESAs Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Long-acting ESAs Sales (2019-2030) & (K Units)
 Figure 15. Global Long-acting ESAs Average Price (US$/Unit) & (2019-2030)
 Figure 16. Long-acting ESAs Report Years Considered
 Figure 17. Long-acting ESAs Sales Share by Manufacturers in 2023
 Figure 18. Global Long-acting ESAs Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Long-acting ESAs Players: Market Share by Revenue in Long-acting ESAs in 2023
 Figure 20. Long-acting ESAs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Long-acting ESAs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Long-acting ESAs Sales Market Share by Country (2019-2030)
 Figure 23. North America Long-acting ESAs Revenue Market Share by Country (2019-2030)
 Figure 24. United States Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Long-acting ESAs Sales Market Share by Country (2019-2030)
 Figure 27. Europe Long-acting ESAs Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Long-acting ESAs Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Long-acting ESAs Revenue Market Share by Region (2019-2030)
 Figure 35. China Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Long-acting ESAs Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Long-acting ESAs Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Long-acting ESAs Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Long-acting ESAs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Long-acting ESAs by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Long-acting ESAs by Type (2019-2030)
 Figure 54. Global Long-acting ESAs Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Long-acting ESAs by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Long-acting ESAs by Application (2019-2030)
 Figure 57. Global Long-acting ESAs Price (US$/Unit) by Application (2019-2030)
 Figure 58. Long-acting ESAs Value Chain
 Figure 59. Long-acting ESAs Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart